CAPVAXIVE 65 ug/.5mL (Pneumococcal 21-valent Conjugate Vaccine INJECTION, SOLUTION) 65 ug/.5mL

CAPVAXIVE 65 ug/0.5mL is a pneumococcal 21-valent conjugate vaccine designed to help prevent pneumococcal disease. This intramuscular injection is suitable for adults aged 18 and older, offering protection against 21 serotypes of Streptococcus pneumoniae.

Strength

65 ug/.5mL

Pack Size

10 SYRINGE in 1 CARTON (0006-4347-02) / .5 mL in 1 SYRINGE (0006-4347-99)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CAPVAXIVE is a vaccine used to help prevent pneumococcal disease caused by Streptococcus pneumoniae. It is designed for adults aged 18 and older, targeting 21 serotypes of the bacterium. This vaccine is administered intramuscularly and is intended to provide immunity against pneumococcal infections, which can lead to serious conditions such as pneumonia, bacteremia, and meningitis. The primary use of CAPVAXIVE is to reduce the risk of these infections in eligible individuals.

Side Effects

Common effects of CAPVAXIVE may include mild to moderate reactions at the injection site, such as pain, redness, or swelling. Some individuals may experience systemic effects like fatigue, headache, or muscle pain. These effects are generally temporary and resolve within a few days. Severe allergic reactions are rare but possible and require immediate medical attention.

Precautions & Warnings

CAPVAXIVE should be administered by healthcare professionals. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use. It is important to inform the healthcare provider about any current illnesses or medications before receiving the vaccine. Proper storage and handling are crucial to maintain the vaccine's effectiveness.

Avoid Interactions

CAPVAXIVE may interact with other medications or vaccines. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving CAPVAXIVE. Alcohol and certain immunosuppressive drugs might affect the vaccine's efficacy, so it is important to consider these factors when planning vaccination.

Frequently Asked Questions

CAPVAXIVE is used to help prevent pneumococcal disease caused by Streptococcus pneumoniae in adults aged 18 and older.

CAPVAXIVE is administered as an intramuscular injection.

Common effects may include pain, redness, or swelling at the injection site, as well as fatigue, headache, or muscle pain.

Individuals with a history of severe allergic reactions to any component of the vaccine should avoid CAPVAXIVE.

It is advisable to discuss any current medications with a healthcare provider before receiving CAPVAXIVE to avoid potential interactions.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.